Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mucosal Melanoma × apatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 55 Carcinoma, Hepatocellular 41 Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 18 Ovarian Neoplasms 18 Colorectal Neoplasms 16 Breast Neoplasms 14 Sarcoma 13 Triple Negative Breast Neoplasms 12 Neoplasms 11 Nasopharyngeal Carcinoma 11 Esophageal Squamous Cell Carcinoma 10 Cholangiocarcinoma 10 Lung Neoplasms 9 Esophageal Neoplasms 9 Osteosarcoma 8 Advanced Gastric Cancer 8 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Recurrence 6 Pancreatic Neoplasms 6 Head and Neck Neoplasms 6 Biliary Tract Neoplasms 6 Uterine Cervical Neoplasms 5 Liver Neoplasms 5 Solid Tumor 4 Melanoma 4 Glioma 4 Thyroid Neoplasms 3 NSCLC 3

Interventions

camrelizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03986515 2019-06-14

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Henan Cancer Hospital

Phase 2 Unknown

Mucosal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡